Sun gets notice for from Taro for termination of merger pact
Domestic drug firm Sun Pharmaceutical, which had acquired Israel-based Taro Pharma for 455 million dollar last year, today said the Israel-based company has terminated the merger agreement.
By PTI |
NEW DELHI: Domestic drug firm Sun Pharmaceutical, which had acquired Israel-based Taro Pharma for 455 million dollar last year, today said the Israel-based company has terminated the merger agreement.
"Sun Pharmaceutical has received a notice from Taro Pharma for the termination of its merger agreement," the company said in a statement without disclosing details.
Mumbai-based Sun Pharmaceutical had last year agreed to acquire Taro Pharma, a multinational generic manufacturer in an all cash deal worth 455 million dollars.
"Sun Pharmaceutical has received a notice from Taro Pharma for the termination of its merger agreement," the company said in a statement without disclosing details.
Mumbai-based Sun Pharmaceutical had last year agreed to acquire Taro Pharma, a multinational generic manufacturer in an all cash deal worth 455 million dollars.
Start a SIP with as low as ₹500 with ET Money App!
Download
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
ADVERTISEMENT
